Nicholas R. Burwick, MD

Video

Diffuse Large B-Cell Lymphoma Highlights From ASH 2023

Author:: Nicholas R. Burwick, MD

Publish date: January 3, 2024

DLBCL highlights from ASH 2023 include chemotherapy-free regimens in frontline and recurrent settings as well as data on racial disparities in DLBC...

Article

Chronic Lymphocytic Leukemia Highlights From ASH 2022

Author:: Nicholas R. Burwick, MD

Publish date: January 11, 2023

CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib + v...